Kazemzadeh, Shokoofeh
Rastegar, Tayebeh
Zangi, Bagher Minaei
Malekzadeh, Mehrnoush
Khanehzad, Maryam
Khanlari, Parastoo
Madadi, Soheila
Bashghareh, Alieh
Hedayatpour, Azim https://orcid.org/0000-0001-8509-9764
Funding for this research was provided by:
Tehran University of Medical Sciences and Health Services (IR.TUMS.MEDICINE.REC.1397.213)
Article History
Received: 28 August 2020
Accepted: 27 December 2020
First Online: 22 January 2021
Compliance with Ethical Standards
:
: The authors declare that they have no conflict of interest.
: This article does not contain any studies with human participants performed by any of the authors. All experiments involving the use of animals were approved by the Institutional Animal Care and Use Committee (IACUC) of the Tehran University of Medical Science. All applicable international, national, and institutional guidelines for the care and use of animals were followed.
: In this study, we used imageJ (ImageJ, RRID:SCR_003070) and GraphPad Prism (GraphPad Prism, RRID:SCR_002798) softwares. We also used anti-MVH (Abcam Cat# ab13840, RRID: AB_443012), anti-ID4 polyclonal (Geno Tex Cat# GTX89728, RRID: AB_ 10,726,681), anti-SCP3 (Abcam Cat# ab15093, RRID: AB_301639), anti-cKit (Fitzgerald Industries International Cat# 10R-3024, RRID: AB_11193325), Goat anti-Rabbit IgG-H&L polyclonal, HRP conjucated (Abcam Cat# ab721, RRID: AB_955447), goat anti-Mouse IgG (H&L)-HRP Conjugate (Bio-Rad Cat# 170–6516, RRID: AB_11125547), goat anti-Rabbit IgG - H&L Polyclonal (FITC Conjugated) (Abcam Cat# ab6717, RRID: AB_955238), and hamster anti-rat CD29 (β1-integrin) (FITC) (BD Biosciences Cat# 555005, RRID: AB_395639) antibodies.